These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29407535)

  • 1. Change in 1-year hospitalization of overall and older patients with major depressive disorder after second-generation antipsychotics augmentation treatment.
    Lin CY; Lai TJ; Wu YH; Chen PK; Lin YF; Chien IC
    J Affect Disord; 2018 Apr; 230():118-124. PubMed ID: 29407535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY.
    Lin CY; Wu YH; Wang HS; Chen PK; Lin YF; Chien IC
    Depress Anxiety; 2016 May; 33(5):435-43. PubMed ID: 26990119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
    Wu YH; Lai CY; Chang YS
    Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Clozapine vs Other Second-Generation Antipsychotics on Hospitalization and Seclusion: A Retrospective Mirror-Image Study in a Japanese Public Psychiatric Hospital.
    Misawa F; Suzuki T; Fujii Y
    J Clin Psychopharmacol; 2017 Dec; 37(6):664-668. PubMed ID: 29045304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder.
    Wu CS; Hsieh MH; Tang CH; Chang CJ
    J Affect Disord; 2016 Jun; 197():189-95. PubMed ID: 26994437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder.
    Fugger G; Bartova L; Dold M; Fabbri C; Fanelli G; Zanardi R; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 114():110480. PubMed ID: 34826558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database.
    Hsieh MH; Chuang PY; Wu CS; Chang CJ; Chung PF; Tang CH
    J Affect Disord; 2017 Aug; 218():327-334. PubMed ID: 28494390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
    Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
    J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and factors in antipsychotic use of outpatients with anxiety disorders in Taiwan, 2005-2013: A population-based study.
    Huang CW; Chiu YW; Chen PJ; Yu NW; Tsai HJ; Chang CM
    Psychiatry Clin Neurosci; 2019 Aug; 73(8):501-507. PubMed ID: 31077503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder.
    Patkar AA; Pae CU
    CNS Drugs; 2013 May; 27 Suppl 1():S29-37. PubMed ID: 23709359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, treatment patterns, and stay characteristics associated with hospitalizations for major depressive disorder.
    Citrome L; Jain R; Tung A; Landsman-Blumberg PB; Kramer K; Ali S
    J Affect Disord; 2019 Apr; 249():378-384. PubMed ID: 30818246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature.
    Wright BM; Eiland EH; Lorenz R
    Pharmacotherapy; 2013 Mar; 33(3):344-59. PubMed ID: 23456734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.
    Han C; Wang SM; Kato M; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2013 Jul; 13(7):851-70. PubMed ID: 23898855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression.
    Gobbi G; Ghabrash MF; Nuñez N; Tabaka J; Di Sante J; Saint-Laurent M; Vida S; Kolivakis T; Low N; Cervantes P; Booij L; Comai S
    Int Clin Psychopharmacol; 2018 Jan; 33(1):34-43. PubMed ID: 28906325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Medication Class and Subsequent Augmentation of Depression Treatment in Privately Insured US Adults.
    Ameli O; Soria-Saucedo R; Smith EG; Cabral HJ; Soley-Bori M; Kazis LE
    J Clin Psychopharmacol; 2017 Jun; 37(3):323-331. PubMed ID: 28338544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.